Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II)

NCT02144753 is registered in ClinicalTrials.gov with Nutrabiotix, LLC as lead sponsor.

NCT NCT02144753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02144753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II)
Lead sponsor
Nutrabiotix, LLC
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2014
Completion date
April 30, 2016
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

constipation-predominant ibs (ibs-c)